Darius Kharabi

CHIEF BUSINESS OFFICER, Kala Pharmaceuticals (United States).

Companies

Kala Pharmaceuticals (United States)CHIEF BUSINESS OFFICER Nov 17, 2021 to now¹

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Kala Pharmaceuticals (United States) KALA41,760 shares²$8.3K at $0.20Oct 22, 2025

As of each latest filing. The line shows shares held over time.

Oct 22, 2025Sold 20,806 shares at $0.83 of Kala Pharmaceuticals (United States)²
Jun 24, 2025Sold 4,511 shares at $4.01 of Kala Pharmaceuticals (United States)³
Jun 3, 2025Sold 730 shares at $3.74 of Kala Pharmaceuticals (United States)⁴
Jan 6, 2025Sold 2,021 shares at $7.63 of Kala Pharmaceuticals (United States)⁵
Jan 6, 2025Granted 10,100 shares of Kala Pharmaceuticals (United States)⁵
Jun 26, 2024Sold 5,158 shares at $4.75 of Kala Pharmaceuticals (United States)⁶
May 31, 2024Sold 231 shares at $6.09 of Kala Pharmaceuticals (United States)⁷
Jan 4, 2024Sold 1,385 shares at $6.73 of Kala Pharmaceuticals (United States)⁸
Jan 4, 2024Granted 4,600 shares of Kala Pharmaceuticals (United States)⁸
Jun 22, 2023Granted 36,847 shares of Kala Pharmaceuticals (United States)⁹
May 31, 2023Granted 2,648 shares of Kala Pharmaceuticals (United States)¹⁰
Mar 10, 2023Granted 6,977 shares of Kala Pharmaceuticals (United States)¹⁰
Jan 4, 2023Granted 9,525 shares of Kala Pharmaceuticals (United States)¹¹
Feb 15, 2022Other 9 shares of Kala Pharmaceuticals (United States)¹⁰
Nov 15, 2021Granted 295,657 shares of Kala Pharmaceuticals (United States)¹²

The numbers on this page point here. Each one links to the record it came from.